GSE130396 8 V 6 NERATINIB HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE130396 8 V 6 NERATINIB HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE130396 8 V 6 NERATINIB HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE130396 8 V 6 NERATINIB HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE130396 8 V 6 NERATINIB HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

leukocyte receptor cluster member 9

Gene

coiled-coil domain containing 200

Gene

lymphocyte antigen 6 family member G5C

Gene

proapoptotic nucleolar protein 1

Gene

cytoplasmic polyadenylated homeobox like 2

Gene

transmembrane protein 9

Gene

serine/threonine kinase 31

Gene

TIR domain containing adaptor protein

Gene

diacylglycerol kinase theta

Gene

solute carrier family 6 member 9

  • Gene

    leukocyte receptor cluster member 9


  • Gene

    coiled-coil domain containing 200


  • Gene

    lymphocyte antigen 6 family member G5C


  • Gene

    proapoptotic nucleolar protein 1


  • Gene

    cytoplasmic polyadenylated homeobox like 2


  • Gene

    transmembrane protein 9


  • Gene

    serine/threonine kinase 31


  • Gene

    TIR domain containing adaptor protein


  • Gene

    diacylglycerol kinase theta


  • Gene

    solute carrier family 6 member 9

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.